Ribomic, Inc. (4591) Stock Statistics & Valuation Metrics

Ribomic, Inc. has a market cap or net worth of ¥4.13B. The enterprise value is ¥1.95K.

Ribomic, Inc. has 56,572,640 shares outstanding. The number of shares has decreased by -2.65% in one year.

Ribomic, Inc.’s return on equity (ROE) is -0.40 and return on invested capital (ROIC) is -42.49%.

The current PE Ratio of Ribomic, Inc. is ―. Ribomic, Inc.’s PEG ratio is 0.45.

In the last 12 months, Ribomic, Inc. had revenue of 3.00M and earned -1.15B in profits. Earnings per share was -23.07.

In the last 12 months, operating cash flow was -250.76M and capital expenditures -4.35M, giving a free cash flow of -255.11M billion.

Ribomic, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Ribomic, Inc. upcoming earnings date is Aug 13, 2026, TBA (Confirmed).

Ribomic, Inc. as a current ratio of 21.68, with Debt / Equity ratio of 0.00%

In the past 12 months, Ribomic, Inc. has paid 1.21M in taxes.

Ribomic, Inc. EV to EBITDA ratio is -2.03, with an EV/FCF ratio of -2.18.

Ribomic, Inc. has ¥2.83B in cash and marketable securities with ¥0.00 in debt, giving a net cash position of ¥2.83B billion.

Gross margin is -33.17%, with operating margin of -40237.73%, and net profit margin of -38178.67%.

The average price target for Ribomic, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―